Cresilon, Inc.
Cresilon is a company that has revolutionized the standard of care by developing plant-based technology to stop traumatic and surgical bleeds in seconds without manual pressure. Their products target veterinary, human trauma, and human surgical applications, with a focus on safe, effective, and reliable bleeding control solutions.
Industries
Nr. of Employees
small (1-50)
Cresilon, Inc.
Patents
Products
Single-use prescription topical hemostatic gel (veterinary)
A single-use, prescription topical hemostatic gel formulated from plant-based polymers to control bleeding on contact for veterinary wounds; provided with Instructions for Use.
Single-use prescription topical hemostatic gel (veterinary)
A single-use, prescription topical hemostatic gel formulated from plant-based polymers to control bleeding on contact for veterinary wounds; provided with Instructions for Use.
Services
Market development and commercialization services for medical device technologies in animal health and planned human trauma and surgical applications.
Production and packaging of single-use, prescription topical hemostatic gel pouches for clinical and veterinary use.
Market development and commercialization services for medical device technologies in animal health and planned human trauma and surgical applications.
Production and packaging of single-use, prescription topical hemostatic gel pouches for clinical and veterinary use.
Expertise Areas
- Hemostasis product development
- Veterinary medical devices
- Plant-based biomaterials
- Medical device manufacturing for single-use products
Key Technologies
- Plant-derived polymer hydrogels
- Topical hemostatic gel formulations
- Single-use sterile pouch packaging
- ISO 10993 biocompatibility testing
News & Updates
Cresilon announced the nationwide launch of TRAUMAGEL in the U.S.
Cresilon announced the nationwide launch of TRAUMAGEL in the U.S.